Gastrointestinal stromal tumors: A multicenter study of 1160 Turkish cases

Background/aims: The aim of this multicenter study was to determine the histopathological features and immunohistochemical profiles of gastrointestinal stromal tumors diagnosed in Turkish patients. Material and Methods: Twenty-eight participating centers registered their gastrointestinal stromal tumor cases on a nationwide database. The diagnosis of gastrointestinal stromal tumor relied upon hematoxylin & eosin features and the results of antibody panel including CD117, CD34, desmin, smooth muscle actin, S-100 protein, and Ki67. The database consisted of parameters including age, gender, location, and all other histopathological and immunohistochemical findings. Statistical analysis was performed using Pearson, Kruskal-Wallis, Mann-Whitney U, and Spearman tests. Results: From all of the gastrointestinal stromal tumors in the database, 1160 cases with a male to female ratio of 1.22 and a mean age of 56.75 years were included in the study. The most common location was the stomach (45.0%), followed by the small intestine, omentum-peritoneum, large intestine, and esophagus (32.0%, 12.6%, 9.3%, 1.1%, respectively). The risk groups were distributed as: 6.1% very low, 21.7% low, 19.3% intermediate, and 53% high-risk cases. Many histopathologic findings were correlated with risk groups. CD117 was positive in 95.3% of gastrointestinal stromal tumors, whereas CD34 was positive in 74.9%, smooth muscle actin in 45.9%, desmin in 9.2%, and S-100 in 19.1.%. Though no significant relation was found between CD117 expression and tumor location, CD34, smooth muscle actin and Ki67 expressions significantly varied in different locations (p=0.001) and risk groups. Conclusions: The results of this multicenter study demonstrated that features other than tumor size and mitosis and immune markers other than CD117 and Ki67 included in the antibody panel seem to be useful as predictive risk factors

Xanthogranulomatous sialadenitis clinically mimicking a malignancy: case report and review of the literature

Background Xanthogranulomatous tissue reaction is a welldocumented process that is most common in kidney. There are other uncommon sites being documented as case reports in the literature. We would like to describe the clinicopathologic findings in a case of xanthogranulomatous sialadenitis that involved the parotid gland, which was clinically thought to be a tumoral mass, and compare it with the 4 previously reported cases

Histological features in abdominal wall endometriosis

Endometriosis is localization of endometrial tissue out of endometrium and myometrium. Location on peritoneum and scar tissue associated with abdominal incision called as abdominal wall endometriosis (AWE). Abdominal wall endometriosis is a rare lesion affection under 1% of effected patients. However, due to increase in laparoscopy, hysterectomy and cesarean section procedurs, the AWE cases are increasing. In this study we aim to analyse AWE rates and evaluate their histologic properties. Endometriosis cases between 2010-2015 were included in study. These cases were evaluated according to localization and out of these 23 cases were revealed as AWE, and in 15 of 23 cases histologic specimens can reach. 317 cases with endometriosis were revealed and 23 (7.2%) were identified as AWE. The mean age was 35±5 (29-45). In 11 (47.8%) cases AWE was developed on scar tissue which have a history of cesarean section procedurs in a mean 3.4 year before. In 10 (66%) cases tubal (ciliary) metaplasia, in 3 (20%) cases hobnail metaplasia and in one case (7%) atypia and mitosis were observed as glandular changes. In 11 (73%) cases myxoid changes, 3 (20%) signet ring-like cells-like changes, 2 (13%) atypical myocytes with giant cells, in one (7%) case thick walled vessels resemble spiral arteries of endometrium and in one case (7%) decidual changes were observed as stromal changes. In this study we highlight the high prevalence of AWE compare to literature. Besides, the wide spectrum of stromal and glandular metaplastic changes could be challenging in proper diagnosis. AWE should keep in mind in the differential diagnosis of lesions in this localization. [Med-Science 2018; 7(2.000): 398-401

Clinicopathologic and molecular characteristics of 523 Turkish gastrointestinal stromal tumor cases: A multicenter study

WOS: 000249454600183

A Single Center Experience; Treatment of HCC with Transplantation, Prognostic Factor Analysis

Joint International Congress of ILTS, ELITA, and LICAGE -- JUN 22-25, 2011 -- Valencia, SPAINWOS: 000291326800470

Living-donor Liver Transplant in 3 Patients With Budd-Chiari Syndrome: Case Report

WOS: 000302517100016PubMed ID: 22352416Budd-Chiari syndrome is a rare but life-threatening disorder characterized by obstruction of the hepatic venous outflow. Treatment depends on the underlying cause, the location, and extent of the obstruction, and the functional capacity of the liver. A stepwise therapeutic approach is commonly accepted. When all other therapy options are unsuccessful, or in case of end-stage liver disease, transplant should be considered. We present case reports of 3 patients with Budd-Chiari syndrome who underwent living-donor liver transplant. Characteristic features of Budd-Chiari syndrome, diagnostic and therapeutic interventions, complications, and overall outcomes are discussed. We believe that when a deceased donor graft is unavailable, a living-donor liver transplant can be a safe option for patients with end-stage liver disease associated with Budd-Chiari syndrome

The Predictive and Prognostic Significance of c-erb-B2, EGFR, PTEN, mTOR, PI3K, p27, and ERCC1 Expression in Hepatocellular Carcinoma

WOS: 000314117000013PubMed ID: 23162604Background: Hepatocellular carcinoma (HCC) is the fifth most common fatal cancer and an important healthcare problem worldwide. There are many studies describing the prognostic and predictive effects of epidermal growth factor receptor 2 (c-erb-B2) and epidermal growth factor receptor 1 (EGFR), transmembrane tyrosine kinases that influence cell growth and proliferation in many tumors. Objectives: The current study aimed to investigate the expression levels of c-erb-B2, EGFR, PTEN, mTOR, PI3K, p27, and ERCC1 in hepatocellular carcinoma (HCC) and their correlation with other clinicopathologic features. Patients and Methods: Fifty HCC cases were stained immunohistochemically with these markers. Correlations between the markers and clinicopathologic characteristics and survival rates were analyzed. Results: No membranous c-erb-B2 staining was seen, whereas cytoplasmic positivity was present in 92% of HCC samples, membranous EGFR was observed in 40%, PI3K was found in all samples, and mTOR was seen in 30%, whereas reduced or absent PTEN expression was observed in 56% of samples and loss of p27 was seen in 92% of the cases. c-erb-B2 and mTOR overexpression, as well as reduced expression of p27, all correlated with multiple tumors (P = 0.041, P < 0.001, and P < 0.001, respectively). P27 loss, and mTOR and EGFR positivity were significantly correlated with AFP (P = 0.047, P = 0.004, and P = 0.008, respectively). Angiolymphatic invasion was more commonly seen in EGFR- and ERCC1-positive cases (P = 0.003 and P = 0.005). EGFR was also correlated with histological grade (P = 0.039). No significant correlations were found among PTEN, PI3K, and the clinicopathological parameters. Disease-free or overall survival rates showed significant differences among therapy modalities, AFP levels, angiolymphatic or lymph node invasions, and ERCC1 and p27 expression levels (P < 0.05). Conclusions: c-erb-B2, EGFR, mTOR, ERCC1 overexpression levels, and loss of p27 may play roles in hepatocarcinogenesis and may be significant predictors of aggressive tumor behavior. These markers were found to be correlated with certain clinicopathologic features, therapy modalities, and survival rates in the current study. These findings may help in planning new, targeted treatment strategies. Published by Kowsar Corp, 2012. cc 3.0.National Liver Transplantation SocietyThis study was supported by National Liver Transplantation Society. This study was partially accepted to be presented as a poster at 24th European Congress of Pathology in Prague, September 08-12, 2012